CNSA 19th Annual Congress |12-14 May 2016 | Cairns Convention Centre | Bridging the gap - Distance, Culture, Workforce and Knowledge

About the Breakfast Sessions

There will be one breakfast session held on Thursday 12 May (prior to the pre-congress symposiums), and two industry supported breakfast sessions will take place on Friday 13 May. 

Breakfast sessions are available for all delegates to attend but spaces are limited and strictly on a first come first basis. A stand-up buffet breakfast will be provided and available 30 minutes before the sessions commence. 

Please click on the links below for more information on the breakfast topics.  In order to attend the breakfast sessions, you will be required to indicate your attendance as part of your registration form.

Click on the links below for more info on the breakfast sessions - 

Thursday 12 May -  Legal considerations and compensation for cancer patients

Friday 13 May -

Breakfast Session 1 - The experience of two oncology units working towards a safer patient experience for IV delivery in the haematology / oncology setting

Breakfast Session 2 - Novel administration technologies of antibodies in anti-cancer treatment

Thursday 12 May

Maurice Blackburn


Title: Legal considerations and compensation for cancer patients

Time: 0815 - 0915 - NB A stand-up buffet breakfast will be provided and available 30 minutes before the sessions commence (7.45am - 8.15am). This will be served outside the meeting room.
 
Presenters:
Jonathan Walsh – Head of Maurice Blackburn’s Queensland Asbestos and Occupational Diseases department
Naomi De Costa – Head of Maurice Blackburn’s Queensland Will Disputes department
Phil Nolan– Head of Maurice Blackburn’s Queensland Superannuation and Insurance Claims department
 
Description:
 
Early and expert legal assistance can significantly improve the compensation outcome for cancer patients and their families.  Many people are unaware that there are a number of legal avenues or insurance benefits that may be available to support a patient at the time of diagnosis, both to provide peace of mind and to relieve the financial burden:

- Capacity – Powers of Attorney, Advance Health Directives/Plans and the role of health care providers
 
- Superannuation and Insurance benefits – often the only source of financial security for cancer sufferers, including the treatment of superannuation benefits in relation to Wills and financial dependents

- Occupational cancer claims - the emerging issues in claims
 
Maurice Blackburn’s industry leading Accredited Specialist Lawyers will provide you with a thorough understanding of a patient’s entitlements and outline the legal process for accessing these benefits.

 

Friday 13 May

Breakfast Session 1

Hospira

Title: The experience of two oncology units working towards a safer patient experience for IV delivery in the haematology / oncology setting

Time: 0715 - 0815 - NB A stand-up buffet breakfast will be provided and available 30 minutes before the sessions commence (6.45am - 7.15am). This will be served outside the meeting room.

Description:

Hospira, a Pfizer company, is committed to providing haematology / oncology healthcare providers with technology and solutions that increase patient & caregiver safety and improve clinical workflow.  Hospira is proud to support this breakfast session where two oncology units will present their experience of working towards safer IV delivery. 

PRESENTERS

Kerrie Curtis, Clinical Nurse Specialist, Day Oncology, Olivia Newton John Cancer and Wellness Centre / Austin Health

‘It's all about improving patient outcomes: Implementing evidence based CVAD maintenance Bundle of Care’

Successful vascular access outcomes is about completing intravenous therapy whilst preserving patients vasculature for the future. There is a plethora of evidence about Insertion Bundles of Care; how to safely and successfully insert vascular devices. However, there remains numerous gaps in evidence for Maintenance Bundles of Care. This session will discuss current evidence-based practices and products for Maintenance Bundles to optimise patient outcomes.

Sean Warren, Snr Product Manager, Hospira Infusion Systems

‘Medication & Infusion Safety in The Oncology Setting’ 

Infusion delivery in the oncology setting is a comparatively complex and specialised area.  Many pump based Dose Error Reduction Systems (DERS) exist within hospitals, however they are often not well utilised in the oncology setting due to the complexity of the medication delivery protocols.  This presentation will highlight current trends in DERS technology and discuss how best to implement medication safety technology within the oncology setting.


Breakfast Session 2

roche

Title: Novel administration technologies of antibodies in anti-cancer treatment

Time: 0715 - 0815 - NB A stand-up buffet breakfast will be provided and available 30 minutes before the sessions commence (6.45am - 7.15am). This will be served outside the meeting room.

Presenter
Sarah Liptrott,  Clinical Nurse Specialist from the European Institute of Oncology, Milan,  Italy.

Description:

Anti-cancer monoclonal antibody treatments are often limited to lengthy intravenous administration. The subcutaneous route is usually limited to fluid volumes of 1-2ml, which is lower than the amounts required for therapeutic use of many anticancer monoclonal antibodies. Recent advances in subcutaneous therapeutic technology have allowed administration of the required volumes of monoclonal antibodies via this route. In this breakfast session, Sarah Liptrott will discuss practical advice and experience with subcutaneous administration of monoclonal antibodies in oncology and haematological malignancies.